1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Point of Care Diagnostics - Global Market Outlook (2015-2022)

Point of Care Diagnostics - Global Market Outlook (2015-2022)

  • January 2016
  • -
  • Stratistics MRC
  • -
  • 121 pages

Summary

Table of Contents

According to Stratistics MRC, the Global Point of Care Diagnostics Market is expected to grow at a CAGR of 9.7 % to reach $32.7 billion by 2022. The speed factor, particularly, is the utmost strength of PoC diagnostics as quicker diagnosis facilitates sooner patient management. Increasing incidence of chronic disorders and contagious diseases, that need portable and quick diagnosis, is estimated to fuel the market growth. Lack of co-ordination among healthcare centers, practitioners, and manufacturers is the major factor hindering the point of care diagnostics market.

Recently, the blood testing segment has been a major contributor to the market, strongly driven by portable glucose monitoring devices. Transmittable diseases, including HIV/AIDS, TB, and hepatitis, will be a rising hub for POC moving ahead. In 2015, North America commanded the POC diagnostics market accounting for more than 40% of the global revenue. Asia Pacific is projected to grow at a productive rate due to the presence of high unmet medical requirements, increase in disposable income and enhancement in healthcare infrastructure in emerging economies. In future, countries such as Japan, China, India, Brazil and Mexico are projected to grow as hot spots for progress of POCT technology.

The key players in global Point of Care Diagnostics market are Roche Diagnostics Limited, Abbott Laboratories, Inc., Johnson & Johnson, Becton, Dickinson And Company, Siemens Healthcare, Bayer Healthcare AG, Nova Biomedical, Abaxis, Inc., Pharmatech Inc., Nipro Diagnostics Inc, Beckman Coulter Inc, BioMérieux, Alere Inc., Danaher Corporation and Spectral Diagnostics.

Technologies Covered:
- Rapid HIV Tests
- Electrodes
- Biosensors
- Continuous Testing
- Drug Testing
- Others
End Users Covered:
- Assisted Living Healthcare Facilities
- Clinics
- Home
- Hospitals
- Laboratories
- Others
Types of Prescription Covered:
- OTC Testing Kits
- Prescription-Based Testing Kits
Products Covered:
- Infectious Diseases Testing Kits
o Hepatitis Testing Kits
o Tropical Diseases Testing Kits
o Influenza Testing Kits
o Sexually-Transmitted Diseases (Stds) Testing Kits
o HIV Testing Kits
o Tuberculosis (TB) Testing Kits
- Pregnancy and Fertility Testing Kits
o Fertility Testing Kits
o Pregnancy Testing Kits
- Glucose Monitoring Kits
o Glucose Monitoring Devices
o Glucose Monitoring Strips
o Lancets
- Coagulation Monitoring Kits
o Activated Clotting Time (Act/Aptt) Testing Kits
o Prothrombin Time (Pt/Inr) Testing Kits
- Hematology Testing Kits
o Hemostasis Assay Kits
o Hemoglobin Assay Kits
- Blood Gas/Electrolytes Testing Kits
- Cardiac Markers
- Cholesterol Test Strips
- Fecal Occult Testing Kits
- Food Pathogens Testing Kits
- Tumor/Cancer Markers
- Urinalysis Testing Kits
- Others


Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2017 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • March 2017
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

Microfluidics Market: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016–2026

  • $ 5000
  • Industry report
  • February 2017
  • by Future Market Insight Global & Consulting Pvt Ltd

With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach ...

Global In-Vitro Diagnostics (IVD) Market: Analysis and Forecast 2017-2023 (Focus on Product Type, Test Type, Application, and Competitive Landscape)

Global In-Vitro Diagnostics (IVD) Market: Analysis and Forecast 2017-2023 (Focus on Product Type, Test Type, Application, and Competitive Landscape)

  • $ 4999
  • Industry report
  • April 2017
  • by BIS Research

IVD Market expected to increase to $76 billion by 2023, increasing its influence over healthcare spending globally Description In-Vitro diagnostics (IVD) is a broad term which refers to the use of medical ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.